Panadol Hot

Quick links to important sections

Panadol Hot

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panadol Hot

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Form Powder for oral solution (Hot drink formulation)
Pharmacological Class Analgesic and Antipyretic
General Purpose Relief from pain and fever
Origin Synthetic

Understanding the Pharmaceutical Identity of Panadol Hot

Panadol Hot is a monocomponent synthetic medicine classified as both an analgesic (pain reliever) and an antipyretic (fever reducer), primarily designed for symptomatic relief. Its core identity is defined by the active ingredient, Acetaminophen, which is recognized internationally by the generic name Paracetamol. This compound is an aniline derivative and is a globally relevant pain and fever agent. Unlike certain other pain relievers, this specific pharmacological class is associated with physiological actions concentrated centrally on the nervous system, with minimal peripheral anti-inflammatory effects.

Panadol Hot: Purpose and Unique Dosage Form

The general therapeutic purpose of Panadol Hot is the focused management of both physical discomfort (pain) and elevated body temperature (fever). A key differentiating feature of this product is its dosage form: a powder contained within a sachet that must be dissolved in hot water, resulting in a hot drink formulation intended for the oral route of administration. This presentation bypasses the need for the body to dissolve a solid tablet. This design supports the potential for faster absorption of the Acetaminophen into the bloodstream compared to solid oral forms, thereby facilitating a quicker initiation of the desired analgesic and antipyretic effects.

Regulatory References

  1. WHO Essential Medicines List (Paracetamol entry)

What side effects are possible with Panadol Hot?

Possible Side Effects and Safety Information

The safety profile for this medicine is based on regulatory documentation classifying potential adverse events by frequency and system involvement.


Adverse Reactions Classified by Frequency

Classification System-Organ Class Involved Documented Adverse Reactions
Very Rare Immune System Disorders, Skin and Subcutaneous Tissue Disorders Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome and toxic epidermal necrolysis; Hypersensitivity reactions (e.g., angioedema, anaphylactic shock).
Frequency Not Known Blood and Lymphatic System Disorders Thrombocytopenia (low platelet count); Agranulocytosis (low white blood cell count).

Clinically Significant and Serious Reactions

The most serious safety consideration is hepatic (liver) toxicity, which is dose-dependent. Exceeding the stated maximum intake poses a severe risk of acute liver failure, potentially leading to hepatic necrosis and acute renal failure (kidney damage).

Safety Restrictions and Limitations

  • Contraindication: The medicine is restricted for use in individuals with a known hypersensitivity to the active substance.
  • Concomitant Use Restriction: This product must not be taken concurrently with any other medicine containing paracetamol due to the significant risk of overdose and subsequent severe liver damage.
  • Population Considerations: Increased susceptibility to liver toxicity exists for patients with pre-existing severe hepatic or renal impairment, or those with chronic alcohol use. Specific caution is required for individuals taking certain medicines that induce liver enzymes.

Regulatory safety information requires immediate discontinuation of the medicine upon the first appearance of signs related to hypersensitivity or severe skin reactions.

Overdose and Emergency Response

Overdose Manifestations and Emergency Action

Overdose involving Acetaminophen, the active ingredient in Panadol Hot, is officially documented to be associated with significant risk of severe hepatic and renal toxicity. Early symptoms may be non-specific, including nausea, vomiting, pallor, and abdominal pain; however, potentially fatal Acute Liver Failure (ALF) can be a delayed outcome. This serious, latent risk necessitates the explicit regulatory instruction to seek immediate medical advice or attention, even if the patient feels well and symptoms have not yet manifested. Urgent hospital referral is required to manage the situation according to established treatment guidelines.

Management and Population Risks

The specific antidote documented for Acetaminophen overdose is N-acetylcysteine (NAC), with maximum protective efficacy obtained when administration is initiated within 8 hours post-ingestion. Clinical assessment requires measurement of Plasma Paracetamol Concentration starting four hours after ingestion. Official labeling notes that the risk of liver damage is greater, and may occur at lower toxic doses, in specific patient populations, including those with non-cirrhotic alcoholic liver disease or who are glutathione deplete due to conditions like malnutrition. Initial supportive procedures described in regulatory sources include considering activated charcoal if ingestion occurred within one hour.

Therapeutic Uses of Panadol Hot

What Panadol Hot Treats: Main Uses and Benefits

Panadol Hot is used to provide supportive symptomatic relief across key therapeutic domains involving heightened symptom expression. Its action is relevant for easing symptoms related to physical discomfort and systemic temperature elevation. The medication supports patients during difficult episodes by easing distress. The product is relevant for easing symptoms in contexts where short-term symptomatic assistance is needed.


Easing Discomfort in Seasonal and Viral Illnesses

This domain is relevant for use of the medication in situations like the common cold and influenza (flu). It helps address symptom clusters that may become intense or disruptive, such as widespread muscular aches, headache, and the general malaise that accompany fever. By addressing both fever and discomfort, it contributes to easing the overall symptom load during periods of heightened symptoms.

Management of Acute Mild to Moderate Pain

The product is relevant for easing symptoms related to physical discomfort of mild to moderate intensity, often used in situations involving recurrent or episodic manifestations. Indications for use generally include temporary relief from tension headaches, backache, toothache, and menstrual discomfort. It provides supportive relief when symptoms interfere with routine activities, assisting with maintaining functional stability.


Quick Fact: Support for Fever and Mild to Moderate Pain Symptoms

Eligibility and Restrictions for Use

Eligibility Profile: Panadol Hot (Regulatory Summary)

This medicine, typically a combination product containing Paracetamol (Acetaminophen) and a decongestant like Phenylephrine, has specific eligibility requirements defined by official regulatory bodies.

Populations Who Must Not Use (Contraindicated)

Contraindication Category Exclusion Criteria
Allergy Known hypersensitivity to Paracetamol, Phenylephrine, or any other ingredients.
Organ Function Severe hepatic impairment (severe liver failure).
Medication Use Current use of other paracetamol-containing products or use within two weeks of stopping Monoamine Oxidase Inhibitors (MAOIs).
Comorbidities Uncontrolled hypertension, severe cardiovascular disease, hyperthyroidism, or diabetes mellitus.

Populations with Restricted or Conditional Use

Use requires medical consultation and caution for individuals with mild to moderate hepatic or renal impairment, chronic alcoholism, severe malnutrition, or low body weight. The medicine is generally not recommended for children and adolescents under 16 years of age for multi-ingredient formulations.

Pregnancy and Lactation Status

Specific combination products are often contraindicated during pregnancy. For breastfeeding, Paracetamol is typically not contraindicated at recommended doses, but advice should be sought due to the other components.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for Acetaminophen (Paracetamol), the active ingredient in Panadol Hot, as defined by government regulatory agencies.

Documented Interaction Restrictions

Co-administration with other medicinal products containing acetaminophen is formally contraindicated due to the severe risk of exceeding the maximum recommended daily dose and causing potentially fatal liver damage.

Interactions Affecting Drug Exposure and Metabolism

Interactions may either increase or decrease the drug’s plasma levels or alter its metabolic pathway:

  • Clearance Inhibitors: Probenecid is documented to reduce paracetamol clearance by inhibiting its conjugation, resulting in an approximate two-fold increase in exposure.
  • Absorption Rate: Agents like Metoclopramide and Domperidone officially increase the rate of absorption, while Cholestyramine reduces it.
  • Metabolic Inducers: Enzyme-inducing medicines (e.g., Carbamazepine, Phenytoin) and herbal products like St. John’s Wort may increase the formation of the toxic paracetamol metabolite, raising the potential for hepatotoxicity.

Pharmacodynamic and Substance Interactions

  • Anticoagulants: Warfarin and other coumarins may have their anticoagulant effect enhanced with prolonged, regular, high-dose use of paracetamol, increasing the risk of bleeding. The label requires monitoring.
  • Alcohol: Regular consumption of three or more alcoholic drinks daily is formally associated with an increased risk of severe liver damage.

Mandatory Administration Timing

To mitigate reduced absorption, doses of Cholestyramine must be separated from paracetamol by at least one hour before or four hours after administration.

Mechanism of Action

The active substance in Panadol Hot, paracetamol (acetaminophen), crosses the blood-brain barrier, exhibiting its primary pharmacological activity within the central nervous system (CNS). Its mechanism of action involves multiple molecular targets and pathways, distinguishing it from peripheral cyclooxygenase (COX) inhibitors.

In the CNS, paracetamol acts as an inhibitor of prostaglandin synthesis, primarily by modulating the activity of COX enzymes, potentially a central variant such as COX-2 or a splice variant of COX-1, where peroxide concentrations are low. This inhibitory interaction reduces the production of prostaglandin E2 ( PGE2) in the hypothalamus, a key regulator of thermal set point. The downstream cascade results in a systemic physiological modulation of thermoregulation.

Additionally, a metabolite, N-arachidonoylphenolamine (AM404), is formed in the CNS. AM404 is an agonist at transient receptor potential vanilloid-1 (TRPV1) receptors and an inhibitor of endocannabinoid reuptake. These interactions lead to the activation of descending inhibitory serotonergic pathways, which contribute to a systemic modulation of nociception processing at the spinal and supraspinal levels.

Dosage and Administration Information

How to Use Panadol Hot: Official Administration Guidelines

Administration of this medicine follows specific parameters focusing on the principles of use. Panadol Hot is a hot drink formulation containing the active ingredient Acetaminophen (Paracetamol) and is intended exclusively for the oral route of administration.

Official Dosing and Frequency

Standard administration involves the use of one to two sachets, delivering a dose range of 500 mg to 1000 mg of Paracetamol per administration. The usage frequency is defined by a required minimum interval: a period of at least 4 hours must elapse between consecutive doses. Adherence to this interval is intended to maintain systemic levels within the appropriate therapeutic range. The maximum cumulative dose of Paracetamol from all sources must not exceed 4000 mg (4 grams) within any 24-hour period.

Preparation and Procedural Constraints

As a powder for oral solution, the medication requires a specific preparation step prior to ingestion: the contents of the sachet must be fully dissolved, typically in hot water, to create the intended drinkable solution. This medication may be administered with or without food. A fundamental constraint on its use is the prohibition of the co-administration of any other product containing Paracetamol or Acetaminophen. Furthermore, for certain populations, such as those with severe hepatic or renal impairment, the labeled instructions mandate a reduction in the total daily dose or an extension of the dosing interval, which may limit the daily intake to 2000 mg.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical studies involving the active ingredient, paracetamol (acetaminophen), have focused on characterizing its properties and effectiveness in managing common conditions, particularly pain and fever associated with the common cold and influenza.

Efficacy in Pain and Fever

Research continues to examine paracetamol's role as a first-line analgesic and antipyretic. Studies frequently measure the time to onset of pain relief and the duration of fever reduction in adult populations. Findings generally indicate that paracetamol can influence the perception of pain and the regulation of body temperature following its administration.

Assessment Area Primary Research Focus
Analgesia Time to meaningful pain reduction
Antipyresis Duration and magnitude of fever decrease

Formulations and Absorption

Specific attention has been paid to the pharmacokinetics of different oral formulations. Studies investigating liquid or powder-based formulations, such as those dissolved in hot water, have explored whether the rate of absorption is altered compared to standard tablet forms. Some research suggests that the presentation as a hot beverage may lead to changes in the speed at which the active substance reaches the systemic circulation, potentially affecting the onset of its observed effects. These pharmacokinetic profiles are assessed through measurements of plasma concentration over time in study participants.

Safety and Tolerability

Profiles of tolerability and adverse events are routinely assessed across all clinical trials. The well-established maximum daily dosage is a key safety parameter, and research often evaluates adherence to this limit among study populations to ensure safe use. No new claims regarding safety profiles or long-term risk reduction have been established in recent clinical literature.

Frequently Asked Questions (FAQ)

Common questions about Panadol Hot (FAQ)

Q: Does Panadol Hot contain paracetamol?

Yes, regulatory documents confirm that Panadol Hot contains the active ingredient paracetamol. This is the component cited in the labeling for its intended actions of temporary pain relief and fever reduction.

Q: What kind of pain can I use Panadol Hot for?

According to the official product information, Panadol Hot is indicated for the temporary relief of mild to moderate pain. The labeling specifies indications for conditions such as headache, muscle ache, and pain associated with colds and flu.

Q: Can I use Panadol Hot for a fever?

Regulatory documents indicate that Panadol Hot possesses antipyretic properties, which means it is used to temporarily help relieve fever. It is specified for reducing fever associated with symptoms of colds and flu.

Q: Is Panadol Hot available as a powder or a tablet?

Panadol Hot is typically available as a powder or granules that are designed to be dissolved in hot water to create a drink. This dosage form is administered as a hot liquid, which is a common way to deliver relief for symptoms of cold and flu.

Q: Are there any age restrictions for using Panadol Hot?

Official product information specifies that Panadol Hot is intended for use in adults and children aged 12 years and over. Full eligibility criteria must be reviewed to ensure the product is appropriate for the intended patient.

Q: How long does Panadol Hot usually take to work?

As a hot drink formulation, the paracetamol component is designed to be readily absorbed. According to official product data, pain relief is typically reported to begin within 30 minutes of administration.

How should Panadol Hot be stored and disposed of?

Official Storage and Disposal Instructions

Official regulatory documents define strict requirements for storing and disposing of Panadol Hot (Paracetamol/Phenylephrine/Ascorbic Acid Powder for Oral Solution) to maintain its stability and ensure environmental safety.

Storage Requirements

The medicine must be stored below 25 C in a dry place and protected from light. It is mandatory that the product is kept out of the sight and reach of children to prevent accidental ingestion. The regulatory labeling explicitly states not to refrigerate or freeze the sachets, and the product must be kept in its original container until use. The medicine must not be used after the printed expiry date (EXP).

Disposal Instructions

Medicines should not be disposed of via wastewater or household waste. Unused or expired product must be disposed of in accordance with local requirements. Patients are instructed to consult a pharmacist on how to safely dispose of any medicine that is no longer needed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panadol Hot found in:

A-Z Index: